Cellebrite (CLBT) officer sets 2026 sell-to-cover for 5,673 shares

Rhea-AI Filing Summary

Cellebrite DI Ltd. (CLBT) was notified that officer David Nicholas Gee filed to sell 5,673 ordinary shares of the company under Rule 144. The shares relate to restricted share units vesting under an S-8 registered compensation plan, and the filing states the sale on 08/21/2026 will be a mandatory, non-discretionary sell-to-cover transaction to satisfy income tax liabilities from vesting of performance share unit awards only. The notice also lists prior small Rule 144 sales over the past three months.

Key Figures

Planned shares to be sold: 5,673 shares Approximate shares outstanding: 250,785,933 shares Planned sale date: 08/21/2026 +4 more

7 metrics

Planned shares to be sold 5,673 shares Ordinary shares covered by the Rule 144 notice for 08/21/2026

Approximate shares outstanding 250,785,933 shares Approximate number of Cellebrite ordinary shares outstanding referenced in the notice

Planned sale date 08/21/2026 Intended date for the Rule 144 sell-to-cover transaction

Recent sale 1 228 shares; $2,966.28 Ordinary shares sold by David Gee on 05/12/2026

Recent sale 2 2,243 shares; $29,383.30 Ordinary shares sold by David Gee on 05/21/2026

Recent sale 3 3,430 shares; $45,093.52 Ordinary shares sold by David Gee on 05/21/2026

Recent sale 4 230 shares; $3,695.59 Ordinary shares sold by David Gee on 08/12/2026

Key Terms

Rule 144, Restricted Share Units, S-8 Registered Plan, sell-to-cover arrangement, +1 more

5 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Restricted Share Units financial

"Restricted Share Units Vested Under an Issuer S-8 Registered Plan"

Restricted share units (RSUs) are a promise from a company to give an employee or service provider actual shares or cash equal to the shares after certain conditions are met, typically staying with the company for a set time or hitting performance targets. Think of them like a time-locked gift card that becomes usable only after you’ve earned it. For investors, RSUs matter because they align employee incentives with company performance and can increase the number of shares outstanding over time, diluting existing ownership and affecting earnings per share.

S-8 Registered Plan regulatory

"Restricted Share Units Vested Under an Issuer S-8 Registered Plan"

sell-to-cover arrangement financial

"pursuant to a mandatory, non-discretionary, sell-to-cover arrangement"

performance share unit awards financial

"upon vesting of performance share unit awards only"

FAQ

What is David Nicholas Gee planning to sell in Cellebrite (CLBT) according to this Form 144?

David Nicholas Gee filed to sell 5,673 ordinary shares of Cellebrite DI Ltd. The shares come from restricted share units vesting under an S‑8 registered compensation plan, and the planned transaction is described as a mandatory sell-to-cover for tax liabilities.

When are the Cellebrite (CLBT) shares covered by this Form 144 expected to be sold?

The notice states the securities are intended to be sold on 08/21/2026. The filing describes this as a mandatory, non-discretionary sell-to-cover arrangement tied to income tax liabilities from vesting performance share unit awards.

What is the stated purpose of David Nicholas Gee’s planned Cellebrite (CLBT) share sale?

The filing explains the sale is solely to satisfy income tax liabilities incurred upon vesting of performance share unit awards. It characterizes the transaction as a mandatory, non-discretionary sell-to-cover rather than an elective sale for other purposes.

How many Cellebrite (CLBT) shares were sold by David Gee in the past three months under Rule 144?

Over the past three months, listed Rule 144 sales total 6,131 shares (228, 2,243, 3,430, and 230 shares). Corresponding proceeds were $2,966.28, $29,383.30, $45,093.52, and $3,695.59, respectively, according to the notice.

What is the approximate number of Cellebrite (CLBT) shares outstanding as referenced in this filing?

The securities information section lists an approximate 250,785,933 ordinary shares outstanding. This figure provides context for the company’s overall equity base relative to the 5,673 shares covered by the planned Rule 144 sale.

Through which broker are the planned Cellebrite (CLBT) shares to be sold?

The planned transaction identifies Morgan Stanley Smith Barney LLC Executive Financial Services at 1 New York Plaza as the broker. This firm would handle the 5,673 ordinary shares sale described in the Rule 144 notice for David Nicholas Gee.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/19/2026 - 07:18 AM Accepted by SEC EDGAR 08/19/2026 - 07:17 AM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001547134
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	CELLEBRITE DI LTD.
SEC File Number	001-40772
Address of Issuer	94 SHLOMO SHMELZER ROAD PETAH TIKVA ISRAEL 4970602
Phone	972-73-394-8000
Name of Person for Whose Account the Securities are To Be Sold	DAVID NICHOLAS GEE
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	OFFICER

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Ordinary shares, par value NIS 0.00001	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	5673	59226.12	250785933	08/21/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Ordinary shares, par value NIS 0.00001	08/20/2026	Restricted Share Units Vested Under an Issuer S-8 Registered Plan	CELLEBRITE DI LTD.			5673	08/20/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
DAVID GEE 94 SHLOMO SHMELZER ROAD PETAH TIKVA L3 4970602	Ordinary shares, par value NIS 0.00001	05/12/2026	228	2966.28
DAVID GEE 94 SHLOMO SHMELZER ROAD PETAH TIKVA L3 4970602	Ordinary shares, par value NIS 0.00001	05/21/2026	2243	29383.3
DAVID GEE 94 SHLOMO SHMELZER ROAD PETAH TIKVA L3 4970602	Ordinary shares, par value NIS 0.00001	05/21/2026	3430	45093.52
DAVID GEE 94 SHLOMO SHMELZER ROAD PETAH TIKVA L3 4970602	Ordinary shares, par value NIS 0.00001	08/12/2026	230	3695.59

144: Remarks and Signature

Remarks	The reporting person intends to sell securities reported herein on 08/21/2026 pursuant to a mandatory, non-discretionary, sell-to-cover arrangement for the purposes of satisfying income tax liabilities incurred upon vesting of performance share unit awards only.
Date of Notice	08/19/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ DAVID NICHOLAS GEE
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)